Prostatectomy in oligometastatic prostate cancer: a call for high-quality evidence.
Prostate Cancer Prostatic Dis
; 2024 Apr 20.
Article
en En
| MEDLINE
| ID: mdl-38643307
ABSTRACT
The systematic review by Saouli et al. investigates the role of radical prostatectomy (RP) in managing oligometastatic prostate cancer (omPCa) [1]. They analyzed the existing literature to assess the oncological and functional outcomes of RP for these patients. RP is feasible and has an acceptable risk of complications. However, the lack of consensus on the definitions of omPCa and the low-quality evidence of the available comparative and retrospective studies, RP in omPCa should not be recommended outside of clinical trials.
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Prostate Cancer Prostatic Dis
Asunto de la revista:
ENDOCRINOLOGIA
/
NEOPLASIAS
/
UROLOGIA
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos